CBCS study materials
CBCS study resources

Modifier 25 Denial, Deductible, and the Appeal Decision

CBCS · Put your knowledge to work in context.

All case studies

Modifier 25 Denial, Deductible, and the Appeal Decision

An orthopedic practice submits 99214-25 for an established patient visit, 20610 for a right-knee large-joint injection, and J1040 (methylprednisolone acetate 80 mg). Charges are $215, $145, and $18. The contract pays 105% of the current Medicare fee schedule: $118.00 for 99214, $72.00 for 20610, and $1.35 per 10 mg for J1040. The payer denies 99214 with CO-97 (service included in another service) and pays the other two lines. The patient has $400 of deductible remaining and 20% coinsurance; there is no secondary coverage. The denial is dated day 38; the payer's reconsideration deadline is 60 days from the denial date and its timely filing limit is 180 days from the date of service. The note documents a separate history and exam addressing the patient's new left hip pain, plus a plan for hip imaging.

1. Compute the contracted allowable for each line and the total. Then compute what the patient owes if the appeal succeeds and if it fails.

Read the worked answer

Allowables (105% of fee schedule):

Line Math Allowable
99214 $118.00 × 1.05 $123.90
20610 $72.00 × 1.05 $75.60
J1040 80 mg = 8 units × $1.35 = $10.80; × 1.05 $11.34
Total $210.84

If the appeal succeeds: total allowed $210.84. The patient still has $400 of deductible remaining, so the entire $210.84 applies to deductible. Insurer pays $0; coinsurance is $0 (deductible is exhausted before coinsurance applies); patient owes $210.84.

If the appeal fails: 99214 is treated as included, allowed $0. Allowed = $75.60 + $11.34 = $86.94, all applied to deductible. Patient owes $86.94.

Key point: the appeal does not produce immediate cash - it produces up to $123.90 of patient liability instead of a write-off, plus protection on audit. That changes the cost-benefit calculation.

2. Should the practice appeal? What documentation actually decides it?

Read the worked answer

Yes - the documentation here supports modifier 25.

Modifier 25 is defensible when a significant, separately identifiable E/M service is performed above and beyond the procedure. The note shows:

  • A distinct problem (new left hip pain) evaluated with its own history and exam.
  • A distinct plan (hip imaging) that is not the injection consent, prep, or post-injection instruction.

What the appeal must contain:

  1. The full encounter note, not an excerpt - the reviewer has to see the hip workup separate from the knee procedure.
  2. A short cover letter mapping the note to the modifier 25 definition, paragraph by paragraph.
  3. The operative note for the injection, showing no E/M-only content was duplicated into it.
  4. The reconsideration form with the claim number and the CO-97 code quoted.

Deadline arithmetic - this is where practices lose appeals: the 60-day clock runs from the denial date (day 38), not the date of service. The reconsideration must be received by roughly day 98 from the DOS. The 180-day timely filing limit is irrelevant now that the claim was accepted, and nothing about it excuses a missed appeal window. Calendar from the denial date and set the internal target at day 75.

3. What is the correct sequence for patient billing and the contractual write-off, and what mistake should be avoided?

Read the worked answer

Sequence:

  1. Place the 99214 balance on hold the moment the denial posts. Suppress statements and do not send to collections.
  2. File the reconsideration within the window computed above.
  3. On final determination, issue one clean patient statement for the correct amount with a plain explanation of the deductible.

The write-off is line-specific, not lump-sum. On 99214 the charge is $215 and the allowable is $123.90, so $91.10 is the contractual adjustment regardless of who pays - the practice can never collect it. If the appeal fails, the entire $123.90 becomes the write-off (allowed = $0) and the patient is billed only the $86.94 attributable to the two paid lines.

The mistake to avoid: billing the patient $215 (or $123.90) for the denied E/M while the appeal is pending, or treating the bundling dispute as a patient responsibility. The payer has not determined the service was non-covered - it determined it was included. Shifting a coding dispute the practice is still contesting onto the patient is a balance-billing and patient-relations problem, and if the appeal later succeeds the practice is left issuing refunds. Appeal first, bill second, and only the allowed amount after the deductible is applied.